Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Patrick Arveux Bruno Coudert |
| Publication date | April 17, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |